Biogen Inc.
0
0
0%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 2.5B 2.6B 2.4B 2.5B
Cost of revenue 674.4M 605M 629.3M 583.5M
Gross profit 1.9B 2.0B 1.8B 1.9B
Operating expense
Research & development 436.1M 399M 434.1M 532.3M
Selling general and admin 594.8M 583.8M 572.5M 680M
Other operating expenses 87.2M 75M 58.1M 57.1M
Operating income 606.5M 851.8M 625.2M 450.6M
Non operating interest income
Income 31.6M 32.3M 23.9M 18.5M
Expense 67.4M 72.6M 60M 60M
Other income expense -13.4M -67.5M -277.9M -117.6M
Pretax income 557.3M 744M 311.2M 291.5M
Tax provision 90.8M 109.2M 70.7M 24.8M
Net income 466.5M 634.8M 240.5M 266.7M
Basic EPS 4.3 1.7 1.8
Diluted EPS 4.3 1.6 1.8
Basic average shares 146.5M 146.1M 145.7M
Diluted average shares 146.7M 146.6M 146.1M
EBITDA 856.1M 1.1B 831.8M 716.8M
Net income from continuing op. 466.5M 634.8M 240.5M 266.7M
Minority interests 0
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 1 hour 4 minutes

08:25
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Main market
09:30 - 16:00
All times are displayed in the America/Santiago timezone (-03, UTC-03:00).